L-PRF IntraSpin™ System

The IntraSpin™ system is designed with a simple three-step protocol which includes drawing and spinning the patients' blood, removing the fibrin clot and processing it in the Xpression™ fabrication kit. No anticoagulant, bovine thrombin, heating, pipetting, second spin, chemical additives or expensive consumables.


What is L-PRF?

By means of the L-PRF technique, certain constituents and signaling substances can be released from autologous blood, which are reintroduced into the wound area to promote natural wound and tissue healing. The therapy is 100% natural and additive-free. Natural growth factors present in the patient´s body are concentrated when using L-PRF. Making use of this autohemotherapy, the patient´s own concentrated platelets and other key blood cells are simply re-introduced into the site of the surgical procedure. As a result, the body´s own constituents are used to release powerful healing proteins and create a scaffold for healing.

The combination of this minimally invasive procedure with the proven products from BioHorizons biologics promotes and accelerates soft tissue and bone regeneration, as scientific studies clearly show. As Professor Nelson R. Pinto once put it: "L-PRF, a human living tissue that challenges the paradigm of osseointegration and tissue regeneration. What we thought impossible yesterday, could be routine tomorrow with L-PRF and natural guided regeneration."

Indications and clinical application

In the last few years, interest and research in this topic has piqued. Science has delivered a wealth of new information on the mechanisms underlying the growth-factor processes of osseointegration and tissue regeneration and has investigated the most suitable therapy concepts in each situation. Supplemented and updated information on therapy concepts are in the latest issue of "Guidelines for the use of L-PRF", written by experts in the field of L-PRF, in order to facilitate compilation of the most effective therapy concepts.1



Nelson R. Pinto1, Andy Temmerman2, Ana B. Castro2, Simone Cortellini2, Wim Teughels2, Marc Quirynen2 University of the Andes, Department of Periodontics and Implant Dentistry, Faculty of Dentistry, Santiago, Chile and Catholic University of Leuven / University Hospitals Leuven, Department of Oral Health Sciences, Periodontology, Leuven, Belgium.

show more show less

BioHorizons® and Camlog®​​​​​​​ may market products only upon approval by the competent authorities.
Not all products and services may be available in every country.